Skip to content

A randomized controlled study of acupoint catgut embedding in the treatment of polycystic ovary syndrome with hyperandrogenism

A randomized controlled study of acupoint catgut embedding in the treatment of polycystic ovary syndrome with hyperandrogenism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083828
Enrollment
Unknown
Registered
2024-05-06
Start date
2024-06-01
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

Group1:acupoint catgut embedding
Group2:Sham-acupoint catgut embedding

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 44 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of traditional Chinese and Western medicine for PCOS; (2) Women in the age range = 18 years and < 45 years; (3) Sign informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with organic diseases of reproductive organs and other reproductive endocrine diseases; (2) Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system and mental illness; (3) people suffering from other chronic diseases (such as hypertension, diabetes, coronary heart disease, etc.); (4) autoimmune disease, cancer, inflammatory disease, infection, pregnancy or lactation; (5) have participated in other clinical trials (such as medication, behavioral intervention, acupuncture, guidance, etc.) within the past 3 months; (6) Severe damage, herpes or serious skin diseases are found at or near the acupuncture site, and those who are allergic to PDO line.

Design outcomes

Primary

MeasureTime frame
Testosterone;

Secondary

MeasureTime frame
menstrual cycle;body mass index;waist-to-hip ratio;LH/FSH ratio;Free androgen index;Homeostasis model assessment of insulin resistance, HOMA-IR;PCOSQ;

Countries

China

Contacts

Public ContactQi Jin

Shanghai Municipal Hospital of Traditional Chinese Medicine

jessyqi0606@163.com+86 131 2220 8396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026